171 related articles for article (PubMed ID: 31402251)
1. Insulin Resistance in Nonobese Renal Allograft Recipients on Maintenance Doses of Cyclosporine or Tacrolimus.
Soypacaci Z; Akgun AO; Sengul S; Keven K
Transplant Proc; 2019 Sep; 51(7):2339-2342. PubMed ID: 31402251
[TBL] [Abstract][Full Text] [Related]
2. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
5. A comparison between cyclosporine and tacrolimus-based immunosuppression for renal allografts: renal function and blood pressure after 5 years.
Muirhead N; House A; Hollomby DJ; Jevnikar AM
Transplant Proc; 2003 Nov; 35(7):2391-4. PubMed ID: 14611965
[TBL] [Abstract][Full Text] [Related]
6. Potential cardiovascular risk factors in paediatric renal transplant recipients.
Ferraris JR; Ghezzi L; Waisman G; Krmar RT
Pediatr Nephrol; 2006 Jan; 21(1):119-25. PubMed ID: 16252106
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Retrospective Cohort Study Using Real-World Evidence From the US Scientific Registry of Transplant Recipients.
Erdman J; Wolfram J; Nimke D; Croy R; Wang X; Weaver T; Schladt D; Fitzsimmons WE
Transplant Proc; 2023 Sep; 55(7):1692-1705. PubMed ID: 37438193
[TBL] [Abstract][Full Text] [Related]
8. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.
Ruangkanchanasetr P; Sanohdontree N; Supaporn T; Sathavarodom N; Satirapoj B
Ann Transplant; 2016 Dec; 21():765-774. PubMed ID: 27980321
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.
Neu AM; Ho PL; Fine RN; Furth SL; Fivush BA
Pediatr Transplant; 2003 Jun; 7(3):217-22. PubMed ID: 12756047
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
[TBL] [Abstract][Full Text] [Related]
11. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.
Cantarovich D; Renou M; Megnigbeto A; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Karam G; Soulillou JP
Transplantation; 2005 Jan; 79(1):72-8. PubMed ID: 15714172
[TBL] [Abstract][Full Text] [Related]
12. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.
Falck P; Vethe NT; Asberg A; Midtvedt K; Bergan S; Reubsaet JL; Holdaas H
Nephrol Dial Transplant; 2008 Mar; 23(3):1048-53. PubMed ID: 17956893
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.
Baid-Agrawal S; Delmonico FL; Tolkoff-Rubin NE; Farrell M; Williams WW; Shih V; Auchincloss H; Cosimi AB; Pascual M
Transplantation; 2004 Apr; 77(8):1199-202. PubMed ID: 15114085
[TBL] [Abstract][Full Text] [Related]
14. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
[TBL] [Abstract][Full Text] [Related]
16. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.
Fuchs U; Klein S; Zittermann A; Ensminger SM; Schulz U; Gummert JF
Ann Transplant; 2014 Jun; 19():300-4. PubMed ID: 24953848
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
Vincenti F; Rostaing L;
Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
[TBL] [Abstract][Full Text] [Related]
18. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
Rathi M; Rajkumar V; Rao N; Sharma A; Kumar S; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
Transplant Proc; 2015 May; 47(4):1158-61. PubMed ID: 26036543
[TBL] [Abstract][Full Text] [Related]
19. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
Plischke M; Riegersperger M; Dunkler D; Heinze G; Kikić Ž; Winkelmayer WC; Sunder-Plassmann G
PLoS One; 2015; 10(8):e0135674. PubMed ID: 26270340
[TBL] [Abstract][Full Text] [Related]
20. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
